Company Filing History:
Years Active: 2014-2016
Title: Innovations by Uwe Stertz: Advances in Pharmaceutical Chemistry
Introduction
Uwe Stertz is a distinguished inventor based in Biberach an der Riss, Germany. With a commendable portfolio comprising three patents, he has made significant contributions to the field of pharmaceutical chemistry. His work focuses on developing novel compounds that address various health conditions.
Latest Patents
Uwe's latest patents highlight his innovative approach to pharmaceutical compositions. One notable invention is related to co-crystals and salts of CCR3 inhibitors. This invention pertains to compounds that act as agents for the treatment and prevention of diseases associated with the CCR3 receptor. Furthermore, he has developed a process and intermediates for preparing GPR40 agonists. This invention includes a detailed methodology for synthesizing these compounds using asymmetric catalytic hydrogenation, showcasing his expertise in chemical processes.
Career Highlights
Uwe Stertz has built his career at Boehringer Ingelheim International GmbH, where he continues to push the boundaries of pharmaceutical research. His dedication to innovation is evident in the quality and impact of his inventions. He has been instrumental in advancing therapeutic compounds that hold promise for treating a variety of medical conditions.
Collaborations
Throughout his career, Uwe has collaborated with talented individuals like Markus Frank and Thorsten Pachur. These partnerships have been essential in refining his inventions and expanding the scope of research at Boehringer Ingelheim, ensuring that cutting-edge solutions are developed efficiently.
Conclusion
Uwe Stertz's contributions to the field of pharmaceutical chemistry underscore his commitment to innovation. His patents not only reflect his inventive prowess but also promise significant advancements in the treatment of diseases through the development of novel compounds. As he continues to work alongside his colleagues at Boehringer Ingelheim, the future looks bright for further innovations in this critical area of medicine.